MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea · Delayed Price · Currency is KRW 1,134.00
-2.00 (-0.18%)
Nov 2, 2026, 3:30 PM KST
MYUNGMOON Pharm co.,Ltd Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 199,825 | 195,247 | 186,443 | 169,567 | 152,135 | 137,760 |
Revenue Growth | 4.75% | 4.72% | 9.95% | 11.46% | 10.44% | 7.75% |
Gross Profit Gross Profit Growth | 110,992 | 106,386 | 104,494 | 94,909 | 77,607 | 61,795 |
Operating Income Operating Income Growth | 1,523 | 6,835 | 1,929 | 963.77 | 6,434 | -5,881 |
Net Income Net Income Growth | -1,669 | 1,895 | -3,035 | -4,525 | 7,868 | -6,865 |
Earnings Per Share EPS Growth | -49.77 | 56.70 | -91.00 | -134.35 | 232.74 | -203.06 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Consolidation Adjustment Consolidation Adjustment Growth | - | -22,556 | - | - | - | - |
Pharmaceutical Sector Pharmaceutical Sector Growth | 235,411 | 208,865 | 200,142 | 179,076 | 173,965 | 160,502 |
Inter Segment Sales Inter Segment Sales Growth | - | - | -21,270 | -18,074 | -30,577 | -30,311 |
Services Segment Services Segment Growth | 7,631 | 8,938 | 7,571 | 8,566 | 8,746 | 7,569 |
Total Total Growth | 199,825 | 195,247 | 186,443 | 169,567 | 152,135 | 137,760 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 24,305 | 6,145 | 4,758 | 11,664 | 9,984 | 10,517 |
Total Debt Total Debt Growth | 87,148 | 98,634 | 87,505 | 90,482 | 83,157 | 84,130 |
Net Cash (Debt) Net Cash Growth | -62,842 | -92,489 | -82,748 | -78,818 | -73,173 | -73,614 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1874.70 | -2766.78 | -2471.19 | -2340.26 | -2164.50 | -2177.55 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3,551 | -1,704 | -1,338 | -5,181 | 5,475 | 855 |
Capital Expenditures CapEx Growth | -6,358 | -6,758 | -771.52 | -2,983 | -1,731 | -374.71 |
Free Cash Flow Free Cash Flow Growth | -9,909 | -8,462 | -2,109 | -8,164 | 3,744 | 480.28 |
Free Cash Flow Growth | - | - | - | - | 679.57% | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 55.55% | 54.49% | 56.05% | 55.97% | 51.01% | 44.86% |
Operating Margin | 0.76% | 3.50% | 1.03% | 0.57% | 4.23% | -4.27% |
Pretax Margin | -1.18% | 1.36% | -2.01% | -2.82% | 1.74% | -4.79% |
Profit Margin | -0.83% | 0.97% | -1.63% | -2.67% | 5.17% | -4.98% |
FCF Margin | -4.96% | -4.33% | -1.13% | -4.81% | 2.46% | 0.35% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 32.63 | - | - | 12.33 | - |
P/FCF Ratio | - | - | - | - | 25.91 | 332.93 |
PS Ratio | 0.19 | 0.32 | 0.33 | 0.45 | 0.64 | 1.16 |